The U.S. Food and Drug Administration (FDA) has approved secukinumab for the treatment of adults with moderate to severe hidradenitis suppurativa (HS). This development, announced today, makes secukinumab the first and only interleukin (IL)-17A inhibitor approved by the FDA for the treatment of HS, which affects approximately 1% of the… Continue Reading FDA approves secukinumab for adults with HS
Many people use eye drops to treat certain eye problems, such as allergies, dryness, irritation, and redness. Recent online search trends show that some people are wondering whether the Food and Drug Administration (FDA) has issued a new warning regarding eye drops sold in the United States. THE QUESTION Is… Continue Reading Yes, the FDA warns against using eye drops from multiple brands due to the risk of infection.
The Food and Drug Administration on Monday expanded its warning not to buy or use eye drops sold by several major retailers, sometimes under their own brands. The warning now includes the product Equate Hydration PF Lubricant Eye Drop 10 mL sold by Walmart, the FDA said. “Walmart is removing… Continue Reading FDA warns against purchasing eye drops manufactured in ‘unsanitary conditions’
Federal regulators are warning consumers to stop using a number of over-the-counter eye drops that may pose an infection risk, marking the latest in a series of alerts this year. against artificial tears. The notice applies to 26 eye drop products marketed under several commercial brands, such as CVS Health,… Continue Reading FDA Warns Consumers Against Using 26 Eye Drops Due to Risk of Infection
Pictured: A boy sitting in a wheelchair on a beach/iStock, ChiccoDodiFC The FDA on Thursday approved Santhera Pharmaceuticals’ new corticosteroid vamorolone, now marketed under the brand name Agamree, for the treatment of Duchenne muscular dystrophy. The announcement was made by Florida-based Catalyst Pharmaceuticals, which paid $90 million upfront in June… Continue Reading FDA Approves New Corticosteroid Treatment Option for DMD Patients | BioSpace
By Alexa Lardieri, Deputy US Health Editor Dailymail.Com 5:33 p.m. October 24, 2023, updated 5:56 p.m. October 24, 2023 Studies examining Xanax had biases that inflated effectiveness results by 40% Researchers looked at five studies and found that only one had actual positive results. READ MORE: Six Little-Known Signs You… Continue Reading Former FDA chief says Xanax is half as effective as doctors thought
CVS Health is considering removing a common type of decongestant from shelves after a U.S. Food and Drug Administration advisory committee said it was ineffective earlier this year. The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications. Although PE has been used… Continue Reading CVS removes decongestant from shelves after FDA panel says it is ineffective